Agilent Technologies Inc (LTS:0HAV)
$ 134.19 +0.34 (+0.25%) Market Cap: 37.86 Bil Enterprise Value: 39.41 Bil PE Ratio: 26.92 PB Ratio: 5.31 GF Score: 95/100

Q1 2025 Agilent Technologies Inc Earnings Call Transcript

Feb 26, 2025 / 09:30PM GMT
Release Date Price: $136.13 (+1.85%)

Key Points

Positve
  • Agilent Technologies Inc (A) exceeded expectations for core revenue growth and EPS in Q1 2025.
  • The company reported strong growth in its digital ecosystem, with digital orders growing in high single digits.
  • Agilent's collaboration with ABB Robotics is expected to enhance lab productivity and efficiency.
  • The Infinity III series has seen great adoption, contributing to increased win rates and customer satisfaction.
  • Agilent's performance in China was strong, with a 50% win rate on stimulus-related tenders, indicating market leadership.
Negative
  • The Applied Markets Group reported a 2% decline in revenue, despite better-than-expected performance related to China's stimulus orders.
  • Currency fluctuations posed a significant headwind, impacting revenue and EPS guidance for the year.
  • The academia and government market saw a 7% decline, with soft results globally.
  • Concerns about potential reductions in NIH funding and tariffs could impact future performance.
  • Gross margins were down due to product mix and currency impacts, with expectations for improvement throughout the year.
Operator

Good afternoon. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the first quarter 2025 Agilent Technologies Inc. earnings conference call. (Operator Instructions). Parmeet Ahuja, you may begin the conference.

Parmeet Ahuja
Agilent Technologies Inc - Vice President - Investor Relations

Thank you, Regina, and welcome, everyone to Agilent's conference call for the first quarter of fiscal year 2025. With me are Padraig McDonnell, Agilent's President and CEO, and Bob McMahon, Agilent's Senior Vice President and CFO. Joining in the Q&A will be Simon May, President of the Life Sciences and Diagnostics Markets Group; Angelika Reimann, President of the Agilent CrossLab Group, and Mike Zhang, President of the Applied Markets Group.

This presentation is being webcast live. The press release for the first quarter financial results, investor presentation and information to supplement today's discussion, along with the recording of this webcast are available on our website at investor.agilent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot